FDA Approves Updated COVID Vaccines from Pfizer and Moderna
The mRNA vaccines are formulated to more closely target currently circulating variants by including a monovalent component that corresponds to the Omicron variant XBB.1.5.
The mRNA vaccines are formulated to more closely target currently circulating variants by including a monovalent component that corresponds to the Omicron variant XBB.1.5.
The US Food and Drug Administration approved a 3-milligram naloxone hydrochloride nasal spray for over-the-counter, nonprescription use for the emergency treatment of known or suspected opioid overdose.
Pfizer's Paxlovid is the fourth drug—and first oral antiviral pill—approved by the FDA to treat COVID-19 in adults.
With these approvals, healthcare professionals now have the option to administer Merck’s measles, mumps, rubella, and varicella vaccines intramuscularly.
Read MoreThe US FDA issued an emergency use authorization for the Lucira COVID-19 & Flu Test, the first over-the-counter (OTC) at-home diagnostic test that can differentiate and detect influenza A and B and SARS-CoV-2.
Read MoreBD received FDA emergency use authorization for its new molecular diagnostic combination test for SARS-CoV-2, Influenza A + B and respiratory syncytial virus (RSV).
Read MoreVero Biotech expects the new indication for its device for rebreathing anesthesia to provide significant benefits to the anesthesiology and surgical care communities.
Read MoreThe association joins other medical organizations in emphasizing the hazards of over-the-counter availability of inhaled epinephrine products for the treatment of asthma.
Read MoreThe FDA expanded its approval of Odactra, a sublingual allergen extract to treat house dust mite-induced allergic rhinitis, to ages 12 through 17.
Read MoreThe US FDA has approved the third Generation Genosyl Delivery System, a tankless inhaled nitric oxide (iNO) therapy device, according to manufacturer Vero Biotech Inc.
Read MoreAstraZeneca’s Airsupra is the first FDA-approved combination of an inhaled corticosteroid and a short-acting beta-agonist for prevention of asthma exacerbations.
Read MoreThe Luna G3 Bilevel S/T 30Vt was granted 510(k) clearance by the US FDA for use as a noninvasive ventilator (NIV), according to manufacturer React Health.
Read MoreThe US FDA recently updated its emergency use authorizations for bivalent Moderna and Pfizer-BioNTech COVID-19 vaccines to include use in children down to 6 months of age. The CDC signed off on the authorizations the following day.
Read MoreDRW Medical’s EXSALTA is the first peristaltic suction device for clearing endotracheal tube secretions for patients on ventilators.
Read MoreThe FDA has authorized bivalent COVID-19 vaccines from Moderna and Pfizer-BioNTech as a single booster dose in younger age groups, according to the agency.
Read More